Aterian IncATER
Price$0.59

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $34.2M-65.5% YoYTTM through 30 Jun 2026
Net Income -$16.9MTTM through 30 Jun 2026
Free Cash Flow -$2.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin56.8%
EBITDA Margin-49.1%
Operating Margin-26.1%
Net Margin-49.3%

Returns

-124.8%ROE
-64.2%ROA

Balance Sheet Health

Debt / Equity0.30x
Current Ratio1.70x
Net Debt-$230Knet cash position
Cash & Equivalents$2.5M

Quality Metrics

Altman Z-Score-43.70
Piotroski F-Score2 / 9
FCF Margin-7.6%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $69M
Diluted EPS
'21'22'23'24'25
FY2025: $-2.39

Dividend

No dividend

Capital Allocation

Capex Intensity0.2%

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.